RxDoctor Payments Data

Robert Shalvoy, MD

Sports Medicine · Providence, RINPI 1154368926

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 41.1% of the total. Reporting peaked in 2019 at $4,853 and has fallen 89.0% since, to $533 in 2025.

$12,461in general payments, 2019–2025

Across 69 payments — averaging $180.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$5K
  • Stryker$3K
  • Kairos Surgical Inc$2K
  • Arthrex$2K
  • Coastal Technology Solutions LLC$261
  • Smith+Nephew$246
  • plus $153 from 4 others

What the payments were for

  • Consulting fees$5,11941%
  • Travel & lodging$4,72238%
  • Food & beverage$2,62021%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,461 in reported general payments places this provider in the 70th percentile of 28 sports medicine providers in Rhode Island.

See all sports medicine providers in Rhode Island

Medicare billing

Part B allowed, 2024
$71,604
Medicare patients
140
Services billed
473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen55$11,195
Meloxicam468$1,809
Etodolac19$305
Alendronate Sodium26$234
Gabapentin27$224
Ibuprofen14$90
Methylprednisolone12$68
Oxycodone Hcl14$55

Paid to pharmacies, not to this prescriber.

Other sports medicine in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →